RT Journal Article
SR Electronic
T1 THROMBOHEMORRHAGIC LESIONS INDUCED BY COMBINED TREATMENT WITH RARE EARTH METALS AND EPINEPHRINE
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 275
OP 281
VO 152
IS 2
A1 G. Gabbiani
A1 M. L. Jacqmin
A1 H. Selye
YR 1966
UL http://jpet.aspetjournals.org/content/152/2/275.abstract
AB Experiments on rats indicate that intravenous administration of any one among 16 rare earth metal trichlorides produces topical thrombohemorrhagic lesions at sites of epinephrine administration. Depending upon dosage and timing, it is possible to produce such lesions either at the epinephrine injection sites alone or in distant organs also, particularly in the kidney. The thrombohemorrhagic lesions produced by ScCl3 plus epinephrine are regularly prevented by pretreatment with alpha adrenergic blocking agents, but not by a series of antihistaminics, antiserotonins or anticoagulants. Apparently, after treatment with rare earth metals, the catecholamine can create local conditions which greatly favor topical thrombus formation even when the clotting of circulating blood is inhibited by an effective anticoagulant such as bishydroxycoumarine. The Williams & Wilkins Comapny